{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T21:46:55Z","timestamp":1762897615240},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1038\/sj.bmt.1702561","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:46:56Z","timestamp":1031154416000},"page":"463-470","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies"],"prefix":"10.1038","volume":"26","author":[{"given":"HT","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Petropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LL","family":"Worth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EA","family":"Felix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HA","family":"Sprigg-Saenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Choroszy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Danielson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Przepiorka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K-W","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,31]]},"reference":[{"key":"BF1702561_CR1","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V75.8.1723.1723","volume":"75","author":"LB Grochow","year":"1990","unstructured":"Grochow LB, Krivit W, Whitely CB, Blazer B . Busulfan disposition in children Blood 1990 75: 1723\u20131727","journal-title":"Blood"},{"key":"BF1702561_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/clpt.1993.108","volume":"54","author":"MB Regazzi","year":"1993","unstructured":"Regazzi MB, Locatelli F, Buggia I et al. Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation Clin Pharmacol Ther 1993 54: 45\u201352","journal-title":"Clin Pharmacol Ther"},{"key":"BF1702561_CR3","first-page":"843","volume":"18","author":"M Hassan","year":"1996","unstructured":"Hassan M, Fasth A, Gerritsen B et al. Busulfan kinetics and limited sampling model in children with leukemia and inherited disorders Bone Marrow Transplant 1996 18: 843\u2013850","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/sj.bmt.1701001","volume":"20","author":"AB Pawlowska","year":"1997","unstructured":"Pawlowska AB, Blazer BR, Angelucci E et al. Relationship of plasma pharmacokinetics of high-dose oral busulfan to the outcome of allogeneic bone marrow transplantation in children with thalassemia Bone Marrow Transplant 1997 20: 915\u2013920","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood.V79.9.2475.2475","volume":"79","author":"G Vassal","year":"1992","unstructured":"Vassal G, Deroussent A, Challine D et al. Is 600mg\/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 1992 79: 2475\u20132479","journal-title":"Blood"},{"key":"BF1702561_CR6","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1182\/blood.V80.9.2425.2425","volume":"80","author":"AM Yeager","year":"1992","unstructured":"Yeager AM, Wagner JE, Graham ML et al. Optimization of busulfan dosage in children undergoing bone marrow transplantation: a pharmacokinetic study of dose escalation Blood 1992 80: 2425\u20132428","journal-title":"Blood"},{"key":"BF1702561_CR7","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V84.7.2144.2144","volume":"84","author":"M Hassan","year":"1994","unstructured":"Hassan M, Ljungman P, Bolme P et al. Busulfan bioavailability Blood 1994 84: 2144\u20132150","journal-title":"Blood"},{"key":"BF1702561_CR8","first-page":"6203","volume":"50","author":"G Vassal","year":"1990","unstructured":"Vassal G, Deroussent A, Hartmann O et al. Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical pharmacological study Cancer Res 1990 50: 6203\u20136207","journal-title":"Cancer Res"},{"key":"BF1702561_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00688324","volume":"37","author":"G Vassal","year":"1996","unstructured":"Vassal G, Koscielny S, Challine D et al. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation Cancer Chemother Pharmacol 1996 37: 247\u2013253","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1702561_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00694339","volume":"25","author":"LB Grochow","year":"1989","unstructured":"Grochow LB, Jones RJ, Brundrett RB et al. Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation Cancer Chemother Pharmacol 1989 25: 55\u201361","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1702561_CR11","first-page":"31","volume":"16","author":"JT Slattery","year":"1995","unstructured":"Slattery JT, Sanders JE, Buckner CD et al. Graft rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics Bone Marrow Transplant 1995 16: 31\u201342","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bmt.1700994","volume":"20","author":"P Ljungman","year":"1997","unstructured":"Ljungman P, Hassan M, Bekassy AN et al. High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients Bone Marrow Transplant 1997 20: 909\u2013913","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR13","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","volume":"89","author":"JT Slattery","year":"1997","unstructured":"Slattery JT, Clift RA, Buckner CD et al. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation Blood 1997 89: 3055\u20133060","journal-title":"Blood"},{"key":"BF1702561_CR14","first-page":"18","volume":"20","author":"L Grochow","year":"1993","unstructured":"Grochow L . Busulfan disposition: the role of therapeutic monitoring in bone marrow transplantation induction regimens Semin Oncol 1993 20: (Suppl.4) 18\u201325","journal-title":"Semin Oncol"},{"key":"BF1702561_CR15","first-page":"225","volume":"17","author":"SP Dix","year":"1996","unstructured":"Dix SP, Wingard R, Mullins RE et al. Association of busulfan under the curve with veno-occlusive disease in patients following BMT Bone Marrow Transplant 1996 17: 225\u2013230","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR16","first-page":"449","volume":"14","author":"D Przepiorka","year":"1994","unstructured":"Przepiorka D, Ippoliti C, Giralt S et al. A phase I\u2013II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation Bone Marrow Transplant 1994 14: 449\u2013453","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0022-3476(78)80601-5","volume":"93","author":"GB Haycock","year":"1978","unstructured":"Haycock GB, Schwartz GJ, Wisotsky DH . Geometric method for measuring body surface area with height\u2013weight formula validated in infants, children and adults J Pediatr 1978 93: 62\u201366","journal-title":"J Pediatr"},{"key":"BF1702561_CR18","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1097\/00007890-199612270-00022","volume":"62","author":"D Przepiorka","year":"1996","unstructured":"Przepiorka D, Ippoliti C, Khouri I et al. Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus Transplantation 1996 62: 1806\u20131810","journal-title":"Transplantation"},{"key":"BF1702561_CR19","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","volume":"6","author":"I Bearman","year":"1988","unstructured":"Bearman I, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 1988 6: 1562\u20131568","journal-title":"J Clin Oncol"},{"key":"BF1702561_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1988","unstructured":"Jones RJ, Lee KSK, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation Transplantation 1988 44: 778\u2013783","journal-title":"Transplantation"},{"key":"BF1702561_CR21","first-page":"867","volume":"41","author":"P Yam","year":"1987","unstructured":"Yam P, Petz LD, Ali S et al. Development of a single probe for documentation of chimerism following bone marrow transplantation Am J Hum Genet 1987 41: 867\u2013881","journal-title":"Am J Hum Genet"},{"key":"BF1702561_CR22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/0378-4347(87)80531-5","volume":"416","author":"WD Henner","year":"1987","unstructured":"Henner WD, Furlong EA, Flaherty MD et al. Measurement of busulfan in plasma by high-performance liquid chromatography J Chromatogr 1987 416: 426\u2013432","journal-title":"J Chromatogr"},{"key":"BF1702561_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0010-468X(79)90025-4","volume":"9","author":"DZ D'Argenio","year":"1979","unstructured":"D'Argenio DZ, Schmitzky A . A program package for simulation and parameter estimation in pharmacokinetics Comput Prog Biomed 1979 9: 115\u2013134","journal-title":"Comput Prog Biomed"},{"key":"BF1702561_CR24","first-page":"1534","volume":"53","author":"G Vassel","year":"1993","unstructured":"Vassel G, Challine D, Koscielny S et al. Chronopharmacology of high-dose busulfan in children Cancer Res 1993 53: 1534\u20131537","journal-title":"Cancer Res"},{"key":"BF1702561_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bmt.1700891","volume":"20","author":"DS Chattergoon","year":"1997","unstructured":"Chattergoon DS, Saunders EF, Klein J et al. An improved limited sampling method for individualized busulfan dosing in bone marrow transplantation in children Bone Marrow Transplant 1997 20: 347\u2013354","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/BF00689702","volume":"28","author":"M Hassan","year":"1991","unstructured":"Hassan M, Oberg G, Bekassy AN et al. Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology Cancer Chemother Pharmacol 1991 28: 130\u2013134","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF1702561_CR27","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.bmt.1701103","volume":"21","author":"JD Down","year":"1998","unstructured":"Down JD, Westerhof GR, Boudewijn A et al. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice Bone Marrow Transplant 1998 21: 327\u2013330","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR28","first-page":"341","volume":"17","author":"T Demirer","year":"1996","unstructured":"Demirer T, Buckner CD, Appelbaum FR et al. Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic bone marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels Bone Marrow Transplant 1996 17: 341\u2013346","journal-title":"Bone Marrow Transplant"},{"key":"BF1702561_CR29","first-page":"1449a","volume":"38","author":"BS Andersson","year":"1997","unstructured":"Andersson BS, Madden T, Hu W et al. Phase I\u2013II study of i.v. busulfan\/cyclophosphamide (BUCY) as stem cell transplantation conditioning therapy Proc Am Assoc Cancer Res 1997 38: 1449a","journal-title":"Proc Am Assoc Cancer Res"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702561","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702561.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:39:14Z","timestamp":1648071554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,31]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,9,1]]}},"alternative-id":["BF1702561"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702561","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,31]]},"assertion":[{"value":"15 February 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2000","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}